365 Crambin-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 1 | 0.2 | 4.62× | not tested | |
| Organic acids and derivatives | 1 | 0.5 | 2.19× | not tested | |
| Organic oxygen compounds | 1 | 0.6 | 1.70× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.6 | 1.57× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00133 | SER | Serine | 2 |
| DB03120 | TSU | p-Toluenesulfonic acid | 2 |
| DB02606 | SBT | 2-Butanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 7 |
| NAmetal | SODIUM ION | 6 |
| SER | SERINE | 2 |
| TSU | PARA-TOLUENE SULFONATE | 2 |
| SBT | 2-BUTANOL | 1 |